Document is current
Any future updates will be listed below
-
Authors
Barrett, James E.
Jones, Allison
Evans, Iona
Reisel, Daniel
Herzog, Chiara https://orcid.org/0000-0002-1572-498X
Chindera, Kantaraja
Kristiansen, Mark
Leavy, Olivia C. https://orcid.org/0000-0002-1503-5535
Manchanda, Ranjit
Bjørge, Line
Zikan, Michal
Cibula, David https://orcid.org/0000-0001-6387-9356
Widschwendter, Martin
- License Information
-
More Information
Article History
Received: 30 December 2020
Accepted: 4 October 2021
First Online: 1 February 2022
Competing interests
: R.M. received an honorarium for grant review from the Israel National Institute for Health Policy Research and from MSD, Astra Zeneca, and GSK for advisory board meetings. UCLB (UCL’s commercialisation company) has filed a patent on some aspects described in the paper—M.W. and J.E.B. are named as inventors on this patent. J.E.B., C.H., and M.W. are shareholders of Sola Diagnostics GmbH, which holds an exclusive licence to the intellectual property that protects the commercialisation of the WID-OC test. All other authors declare no competing interests.
